High Resolution Diffusion Weighted Imaging in Prostate

Recruiting now

Conditions studied: Prostate Cancer, Prostate Disease

In brief

hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI

Key facts

Study ID

NCT06636747

Run by

The First Affiliated Hospital with Nanjing Medical University

People needed

500

Starts

2023-08-01

Expected to finish

2026-07-31

Last updated by the study team

2024-10-15

Who can join

Age: 55 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps;
• Complete clinical information.

You may not qualify if…

• Men were excluded if they were using 5-alpha-reductase inhibitors at time of examination or has used such during the previous six months; or if they had a previous history of prostatic biopsy, prostatic surgery, or treatment for PCa

Where it is running

• The First Affiliated Hospital with Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)
• Yu-Dong Zhang — Nanjing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.